2[2]Watanabe T,Tanaka M,Watanabe K.Research and development of the free radical scavenger edaravone as a neuroprotectant[J].Yakugaku Zasshi,2004,124(3):99-111.
3[3]Giffard RG,Jaffe RA.Advances in understanding protection from cerebral ischemia[J].Curr Opin Anaesthesiol,2002,15 (5):495-500.
4[4]Inatomi Y,Takita T,Yonehara T,et al.Efficacy of edaravone in cardioembolic stroke[J ].Intern Med,2006,45 (5):253-257.
5[5]Nito C,Kamiya T,Amemiya S,et al.The neuroprotective effect of a free radical scavenger and mild hypothermia following transient focal ischemia in rats[J].Acta Neurochir Suppl,2003,86(4):199-203.
5Uno M,Kitazato KT,Suzue A,et al. Inhibition of brain damage byedaravone, a free radical scavenger, can be monitored by plasma biomarkers that detect oxidative and astrocyte damage in patients with acute cerebral infarction[J]. Free Radic Bio Med. 2005,39(8):1109-1116.
6Amemiya S, Kamiya T, Nito C, et al. Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats[J]. Eur J Pharmacol, 2005,516 (2) : 125-130.
7Oishi M,Mochizuki Y, Hara M,et al. Effects of sodium ozagrel on hemostatic markers and cerebral blood flow in lacunar infarction [J]. Clin Neuropharmacol, 1996,19(6) : 526-531.
8Tanahashi N. Antithrombotic therapy in cerebral infarction [J]. Rinsho Shinkeigaku,2000,40(12) :1251-1253.
